Showing results (3431-3440 of 6,511) with videos related to
Sort By:
Pageof 652
Experimental Hematology|February 3, 2020
Clonal hematopoiesis in hematological disorders: Three different scenariosSabina Swierczek, Josef T PrchalExperimental Hematology|January 22, 2019
Application of induced pluripotent stem cells to primary immunodeficiency diseasesPeter Karagiannis, Shinya Yamanaka, Megumu K SaitoExperimental Hematology|June 1, 1978
Growth of canine T-lymphocyte colonies in vitroF D Wilson, M Shifrine, M E Gershwin, et al.Experimental Hematology|December 8, 2020
How Hematopoietic Stem Cells Respond to Irradiation: Similarities and Differences between Low and High Doses of Ionizing RadiationsElia Henry, Marie-Laure ArcangeliExperimental Hematology|December 5, 2020
Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitationPia Sommerkamp, François E Mercier, Adam C Wilkinson, et al.Experimental Hematology|September 1, 1977
Temporal transition in the site of rat erythropoietin productionD F Gruber, J R Zucali, J Wleklinski, et al.Experimental Hematology|February 1, 1987
Evidence for immunosuppression by high-dose gammaglobulinK Kawada, P I TerasakiExperimental Hematology|March 1, 1987
Charcoal-dextran treatment of fetal bovine serum removes an inhibitor of human CFU-megakaryocytesD L Lindquist, P A de AlarconExperimental Hematology|September 27, 2013
Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivoDanielle N Yarde, Rebecca A Nace, Stephen J RussellExperimental Hematology|September 1, 1987
The role of erythropoietin, megakaryocyte colony-stimulating factor, and T-cell-derived factors on human megakaryocyte colony formation: evidence for T-cell-mediated and T-cell-independent stem cell proliferationD Geissler, G Konwalinka, C Peschel, et al.Pageof 652